Yahoo Web Search

Search results

1. • 

     How to Use Creatine to Optimize Your Well-Being and Training Results

     Verywell Fit via Yahoo News· 13 hours ago

     Boost your athletic performance and see muscle gains safely with creatine. Learn more about creatine...

2. • Study investigates cardiac cell regeneration in search of novel therapeutics

     Medical Xpress· 4 days ago

     With that in mind, Mahmoud Salama Ahmed, Ph.D., and an international team of researchers have completed an investigation to uncover novel therapeutics or ...

3. • FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE...

     Yucaipa News Mirror· 4 days ago

     Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle ...

4. • 

     Some forms of augmented brain stimulation recommended for major depression

     Medical Xpress· 5 days ago

     TMS was approved by the Food and Drug Administration for treatment of MDD in 2008. It uses pulsed...

5. • Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial...

     Nature· 7 days ago

     All procedures in the protocol were in compliance with applicable animal welfare acts and were approved by the local IACUC. The study design was based on the principles of ...

6. • 

     Inflammatory Acne

     Health via Yahoo News· 4 days ago

     Inflammatory acne appears as discolored, swollen, and painful bumps on the body. It can be treated with skincare or prescriptions from a dermatologist.

7. • 

     Why are whole-body deodorants suddenly everywhere?

     Vox· 13 hours ago

     Whole-body deodorants are upon us. This spring, legacy brands jumped on board en masse: Since the start of 2024 alone, Secret, Dove, Old Spice, and...

8. • Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib...

     Benzinga· 6 days ago

     Across 50 treated patients, palazestrant (OP-1250) in combination with ribociclib was well tolerated with no new safety signals or increased toxicity and no clinically meaningful impact on drug exposure of either

9. • MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints

     WKBN 27 Youngstown· 2 days ago

     As components of the mCRM System, the devices are designed to work together wirelessly to coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy, provide rate-responsive...

10. • AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...

      Tri-County Times· 4 days ago

      - AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)